Cargando…

Pitavastatin Regulates Ang II Induced Proliferation and Migration via IGFBP-5 in VSMC

Angiotensin II (Ang II), a key mediator of hypertensive, causes structural changes in the arteries (vascular remodeling), which involve alterations in cell growth, vascular smooth muscle cell (VSMC) hypertrophy. Ang II promotes fibrotic factor like IGFBP5, which mediates the profibrotic effects of A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ha, Yu Mi, Nam, Ju-Ock, Kang, Young Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Physiological Society and The Korean Society of Pharmacology 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637352/ https://www.ncbi.nlm.nih.gov/pubmed/26557016 http://dx.doi.org/10.4196/kjpp.2015.19.6.499

Ejemplares similares

Luteolin Inhibits Angiotensin II-Stimulated VSMC Proliferation and Migration through Downregulation of Akt Phosphorylation
por: Xu, Tongda, et al.
Publicado: (2015)

circACTA2 mediates Ang II-induced VSMC senescence by modulation of the interaction of ILF3 with CDK4 mRNA
por: Ma, Ying, et al.
Publicado: (2021)

Correction for: circACTA2 mediates Ang II-induced VSMC senescence by modulation of the interaction of ILF3 with CDK4 mRNA
por: Ma, Ying, et al.
Publicado: (2022)

PPARγ Inhibits VSMC Proliferation and Migration via Attenuating Oxidative Stress through Upregulating UCP2
por: Zhou, Yi, et al.
Publicado: (2016)

Platelet-derived microvesicles induce calcium oscillations and promote VSMC migration via TRPV4
por: Li, Shan-Shan, et al.
Publicado: (2021)

NLRP3 inflammasome activation contributes to VSMC phenotypic transformation and proliferation in hypertension
por: Sun, Hai-Jian, et al.
Publicado: (2017)

Pitavastatin Is a Highly Potent Inhibitor of T-Cell Proliferation
por: Voss, Linda, et al.
Publicado: (2021)

miRNA-145 inhibits VSMC proliferation by targeting CD40
por: Guo, Xin, et al.
Publicado: (2016)

Effects of Kindlin-2 on proliferation and migration of VSMC and integrinβ1 andβ3 activity via FAK-PI3K signaling pathway
por: Wu, Xiaolin, et al.
Publicado: (2020)

Soluble N-cadherin: A novel inhibitor of VSMC proliferation and intimal thickening
por: Lyon, Cressida A., et al.
Publicado: (2016)

Mesoglycan attenuates VSMC proliferation through activation of AMP-activated protein kinase and mTOR
por: Lee, Kyung Young, et al.
Publicado: (2016)

Pleiotropic effects of pitavastatin
por: Davignon, Jean
Publicado: (2012)

5′-tiRNA-Cys-GCA regulates VSMC proliferation and phenotypic transition by targeting STAT4 in aortic dissection
por: Zong, Tingyu, et al.
Publicado: (2021)

B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3
por: Fan, Xiaoyan, et al.
Publicado: (2018)

Physiological and pathological roles of Ang II and Ang- (1-7) in the female reproductive system
por: Liu, Yuanyuan, et al.
Publicado: (2022)

Digoxin inhibits PDGF-BB-induced VSMC proliferation and migration through an increase in ILK signaling and attenuates neointima formation following carotid injury
por: YAN, GAOLIANG, et al.
Publicado: (2015)

Exosomes from nicotine-stimulated macrophages accelerate atherosclerosis through miR-21-3p/PTEN-mediated VSMC migration and proliferation
por: Zhu, Jumo, et al.
Publicado: (2019)

Interaction of the pitavastatin with model membranes
por: Shurshalova, Guzel S., et al.
Publicado: (2021)

SENP2 Promotes VSMC Phenotypic Switching via Myocardin De-SUMOylation
por: Liang, Min, et al.
Publicado: (2022)

Comparative evaluation of biased agonists Sarcosine(1), d‐Alanine (8) ‐Angiotensin (Ang) II (SD Ang II) and Sarcosine(1), Isoleucine (8) ‐Ang II (SI Ang II) and their radioiodinated congeners binding to rat liver membrane AT(1) receptors
por: Noto, Natalia M., et al.
Publicado: (2023)

AngII-induced glomerular mesangial cell proliferation inhibited by losartan via changes in intracellular calcium ion concentration
por: Qiu, Guoying, et al.
Publicado: (2013)

Fluvastatin inhibits advanced glycation end products-induced proliferation, migration, and extracellular matrix accumulation in vascular smooth muscle cells by targeting connective tissue growth factor
por: Hwang, Ae-Rang, et al.
Publicado: (2018)

MicroRNA-134-5p Regulates Media Degeneration through Inhibiting VSMC Phenotypic Switch and Migration in Thoracic Aortic Dissection
por: Wang, Ying, et al.
Publicado: (2019)

AKT Mediates Adiponectin-Dependent Regulation of VSMC Phenotype
por: Cullen, Abigail E., et al.
Publicado: (2023)

Mitochondria spatially and temporally modulate VSMC phenotypes via interacting with cytoskeleton in cardiovascular diseases
por: Li, Jingwen, et al.
Publicado: (2023)

Dual Role of CREB in The Regulation of VSMC Proliferation: Mode of Activation Determines Pro- or Anti-Mitogenic Function
por: Hudson, Claire, et al.
Publicado: (2018)

Lysyl oxidase (LOX) limits VSMC proliferation and neointimal thickening through its extracellular enzymatic activity
por: Varona, Saray, et al.
Publicado: (2018)

Ferulic Acid Alleviates Atherosclerotic Plaques by Inhibiting VSMC Proliferation Through the NO/p21 Signaling pathway
por: Wu, Xiaoyun, et al.
Publicado: (2022)

Pitavastatin in cardiometabolic disease: therapeutic profile
por: Masana, Luis
Publicado: (2013)

Kaempferol Prevents Against Ang II-induced Cardiac Remodeling Through Attenuating Ang II-induced Inflammation and Oxidative Stress
por: Du, Yao, et al.
Publicado: (2019)

Inhibitory Effect of β-Sitosterol on the Ang II-Induced Proliferation of A7r5 Aortic Smooth Muscle Cells
por: Chen, Yuankun, et al.
Publicado: (2023)

MIA SH3 Domain ER Export Factor 3 Deficiency Prevents Neointimal Formation by Restoring BAT-Like PVAT and Decreasing VSMC Proliferation and Migration
por: Lei, Yu, et al.
Publicado: (2021)

Evaluation of the Pharmacokinetic Drug–Drug Interaction between Micronized Fenofibrate and Pitavastatin in Healthy Volunteers
por: Lee, Hae Won, et al.
Publicado: (2020)

Differential Diabetogenic Effect of Pitavastatin and Rosuvastatin, in vitro and in vivo
por: Cho, Yongin, et al.
Publicado: (2020)

Activation of Bone Marrow-Derived Cells Angiotensin (Ang) II Type 1 Receptor by Ang II Promotes Atherosclerotic Plaque Vulnerability
por: Pellegrin, Maxime, et al.
Publicado: (2018)

Role of Renin-Angiotensin System Components in Atherosclerosis: Focus on Ang-II, ACE2, and Ang-1–7
por: Silva, Gabriela M., et al.
Publicado: (2020)

IGFBP5 antisense and short hairpin RNA (shRNA) constructs improve erectile function by inducing cavernosum angiogenesis in diabetic mice
por: Ock, Jiyeon, et al.
Publicado: (2022)

Vascular smooth muscle-MAPK14 is required for neointimal hyperplasia by suppressing VSMC differentiation and inducing proliferation and inflammation
por: Wu, Wen, et al.
Publicado: (2019)

Citri reticulatae Pericarpium attenuates Ang II-induced pathological cardiac hypertrophy via upregulating peroxisome proliferator-activated receptors gamma
por: Ni, Gehui, et al.
Publicado: (2020)

The sympathetic transmitter norepinephrine inhibits VSMC proliferation induced by TGFβ by suppressing the expression of the TGFβ receptor ALK5 in aorta remodeling
por: Hu, Zhipeng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u95j9jipnsk578d380nveigoi4